Evidence map›Paper›PMID 35954328›Full record

ReviewCancers2022

A Synopsis Clonal Hematopoiesis of Indeterminate Potential in Hematology.

Maroun Bou Zerdan, Lewis Nasr, Ludovic Saba, Paul Meouchy, Nadine Safi, Sabine Allam, Jenish Bhandari, Chakra P Chaulagain

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. African journal of laboratory medicine · 2026
    Article
  2. Article
  3. CHIPing Away at Proteomics to Find Correlations with Myeloid Neoplasms.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maroun Bou ZerdanDepartment of Internal Medicine, SUNY Upstate Medical University, New York, NY 10009, USA.ORCID 0000-0002-9229-3079
Lewis NasrFaculty of Medicine, Saint-Joseph University, Beirut P.O. Box 100, Lebanon.
Ludovic SabaFaculty of Medicine, Saint-Joseph University, Beirut P.O. Box 100, Lebanon.
Paul MeouchyDepartment of Internal Medicine, Division of Hematology and Oncology, Naef K. Basile Cancer Institute, American University of Beirut Medical Center, Beirut P.O. Box 100, Lebanon.
Nadine SafiDepartment of Internal Medicine, Division of Hematology and Oncology, Naef K. Basile Cancer Institute, American University of Beirut Medical Center, Beirut P.O. Box 100, Lebanon.
Sabine AllamDepartment of Medicine and Medical Sciences, University of Balamand, Balamand P.O. Box 100, Lebanon.
Jenish BhandariDepartment of Internal Medicine, SUNY Upstate Medical University, New York, NY 10009, USA.
Chakra P ChaulagainDepartment of Hematology-Oncology, Myeloma and Amyloidosis Program, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL 33326, USA.ORCID 0000-0002-4641-2217

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clonal hematopoiesis of indeterminate potential can be defined as genetic mutations that correlate in hematologic neoplasia such as myelodysplastic syndrome. Patients with cytopenia increasingly undergo molecular genetic tests of peripheral blood or bone marrow for diagnostic purposes. Recently, a new entity has been demarcated to lessen the risk of incorrect diagnoses of hematologic malignancies. This new entity is a potential precursor of myeloid diseases, analogous to monoclonal gammopathy of undetermined significance as a potential precursor of multiple myeloma.

Indexed as

chimeric antigen receptor T-cell therapyclonal hematopoeisishematologymutationsmyeloma

Identifiers

PMID35954328
PMCPMC9367563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.